2022 annual financial data
Cadrenal Therapeutics 2022 Net margin
Direct answer
Net margin was Not calculable.
Operating income was -2,701,630 USD and net income was -6,714,329 USD.
Operating cash flow was -1,204,770 USD.
Get free Cadrenal Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- Not available
- Operating income
- -2,701,630 USD
- Net income
- -6,714,329 USD
- Operating cash flow
- -1,204,770 USD
Explore related company data
View all 2022 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Cadrenal Therapeutics financial years